MétaCan
Menu
← Back to cohort
Record W7117314747 · doi:10.1002/alz70859_101318

The Therapeutic Role of Monocytes in Alzheimer's Disease: Effects on Vascular Amyloid‐Beta Transport

2025· article· en· W7117314747 on OpenAlexaff
Ayanna Arneaud, Serge Rivest, Nataly Laflamme

Bibliographic record

VenueAlzheimer s & Dementia · 2025
Typearticle
Languageen
FieldMedicine
TopicAlzheimer's disease research and treatments
Canadian institutionsUniversité Laval
Fundersnot available
KeywordsInnate immune systemImmune systemNOD2InflammationMonocyteDual roleTherapeutic approachEndothelium

Abstract

fetched live from OpenAlex

BACKGROUND: Alzheimer's disease (AD) is a neurodegenerative disease with no cure, and amyloid-beta (AB) accumulation is one of its key pathological hallmarks. Cerebral Amyloid Angiopathy (CAA), characterized by AB deposition in cerebral vasculature, is increasingly recognized as a significant contributor to Alzheimer's Disease development. Monocytes, which are key innate immune cells, play a crucial role in AB clearance. However, their therapeutic potential remains underexplored in the context of CAA. We hypothesize that the activation of the Nucleotide-binding oligomerization domain 2 (NOD2) receptor by Muramyl Dipeptide (MDP) to convert classical monocytes into non-classical, patrolling monocytes, will enhance AB clearance in APP/PS1 mice. Additionally, this favourable effect will be further amplified in combination with a glucocorticoid such as dexamethasone (Dex) due to its ability to upregulate key efflux transporters ABCB1 and LRP-1 while providing anti-inflammatory properties concurrently. In order to address this hypothesis, we'll start by investigating the implications of this NOD2 receptor and glucocorticoids on the modulation of monocytes and memory. We will also investigate the mechanisms of AB clearance. METHOD: We used wild-type, NOD2 knockout (KO), and APP/PS1 transgenic mouse models to assess the effects of MDP and Dex on monocyte modulation, transporter expression, and cognitive function. Flow cytometry was used to analyze monocyte populations, while transporter expression was evaluated by western blot. Memory was assessed using the Novel Object Recognition Task. RESULT: MDP induced a switch from classical (LyChigh) to patrolling monocytes (Ly6Clow), suggesting enhanced AB clearance, an effect that was absent in our NOD2 KO mice. Dex treatments significantly increased ABCB1 and LRP-1 expression in APP/PS1 mice, suggesting improved AB efflux across the blood-brain barrier (BBB). Notably, the combination of MDP and Dex resulted in a synergistic effect, significantly enhancing transporter expression and delaying memory decline in APP/PS1 mice. CONCLUSION: These findings highlight NOD2 as a promising therapeutic target for modulating innate immune responses to enhance AB clearance. Additionally, the combination of NOD2 activation and glucocorticoids offers a novel dual approach to AD and CAA treatments by promoting both immune and BBB-mediated clearance of AB while reducing inflammation.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.004

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.016
GPT teacher head0.290
Teacher spread0.275 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueAlzheimer s & Dementia→Same topicAlzheimer's disease research and treatments→French-language works237,207→